Summary: Since its introduction, the multiple sleep latency test (MSLT) has played a major role in the diagnosis of narcolepsy. We assessed its diagnostic value in a series of 2,083 subjects of whom 170 (8.2%) were diagnosed with narcolepsy. The sensitivity of the combination of two or more sleep onset rapid eye movement (REM) periods (SOREMPs) with a mean sleep latency of <5 minutes on an initial MSLT was 70% with a specificity of 97%, but 30% of all subjects with this combination of findings did not have narcolepsy. In some narcoleptics who had more than one MSLT, the proportion of naps with SOREMPs varied substantially from the initial MSLT to the follow-up test. The highest specificity (99.2%) and positive predictive value (PPV) (87%) for MSLT findings was obtained with the criteria of three or more SOREMPs combined with a mean sleep latency of <5 minutes, but the sensitivity of this combination was only 46%. The combination of a SOREMP with a sleep latency < 10 minutes on polysomnography yielded a specificity (98.9%) and PPV (73%) almost equal to those obtained from combinations of MSLT findings, but the sensitivity was much lower. Our results suggest that the MSLT cannot be used in isolation to confirm or exclude narcolepsy, is indicated only in selected patients with excessive daytime sleepiness, and is most valuable when interpreted in conjunction with clinical findings.
control subjects showed no SOREMPs during singlenap tests.
The need for a diagnostic test for narcolepsy increased after the discoveries of sleep apnea, periodic leg movements, and other disorders of excessive sleepiness made it apparent that excessive daytime sleepiness could be caused by a variety of disorders. The development of the multiple sleep latency test (MSLT) (9) provided an opportunity to analyze several sleep onset episodes in a single patient. In the first reports of MSLT findings in narcolepsy, 100% of 40 narcoleptics had two or more SOREMPs, while none of 14 normal controls had any SOREMPs (10, 11) . Based on these and other findings, the 1979 Diagnostic Classification of Sleep and Arousal Disorders indicated that SOREMPs were "highly diagnostic" of narcolepsy, provided that other causes of SOREMPs had been excluded, including drug withdrawal, REM sleep deprivation from obstructive sleep apnea or other causes, alcoholism, psychotic depression, and sleep-wake schedule disturbances (12) .
Additional studies were reported in the 1980s. Mitier (13) found that 8% of 63 non-narcoleptic patients with excessive sleepiness had one SOREMP on MSLT, and none had more than one. Amira et al. (14) found that 84% of narcoleptics had two or more SOREMPs, 57% of narcoleptics had a mean sleep latency on the MSLT of <5 minutes, and only one of 83 non-narcoleptic subjects had two or more SOREMPs. In this study, the proportion of subjects with two or more SOREMPs who had narcolepsy [the positive predictive value (PPV)] was 98%, and the proportion of subjects without two or more SOREMPs who did not have narcolepsy [the negative predictive value (NPV)] was 89%.
Although the results described above suggest that the MSLT is highly useful for the diagnosis of narcolepsy, the data for these studies were gathered before the recognition that sleep apnea is a much more common cause of daytime sleepiness than narcolepsy and that SOREMPs are not uncommon in patients with sleep apnea. In the study by Amira et al. (14) , only 13/144 subjects were diagnosed with sleep apnea, whereas currently the majority of patients seen at most sleep centers have sleep-related breathing disorders. In a recent series, 25% of 187 patients with obstructive sleep apnea but without symptoms of narcolepsy had two or more sleep onset REM periods on an MSLT (15) . Sleep onset REM periods are common in PraderWilli syndrome (16) and also may occur with KleineLevin syndrome (17) in patients with frequent periodic leg movements (18) and in subjects who do not complain of sleepiness (19) .
As sleep apnea is now the most common diagnosis at sleep centers, the predictive value of SOREMPs may differ from the predictive value determined from series that included few patients with sleep apnea. The purpose of this study, therefore, was to assess the sensitivity, specificity, and predictive value of the MSLT for the diagnosis of narcolepsy in a large series of patients.
METHODS
We reviewed the results of all 2,472 MSLTs performed at the University of Michigan Sleep Disorders Center between January 1984 and March 1996. From this database, we identified 2,083 MSLTs that were done as part of an initial diagnostic evaluation in patients who were free of psychoactive or REM sleepsuppressing medications at the time of sleep recordings. We then retrospectively reviewed MSLT and polysornnographic data on these subjects. Polysornnographic data were available for all except 36 subjects. Nighttime polysornnography and daytime MSLTs were performed with subjects on a regular schedule. Duration of polysomnography was almost always 8 or 9 hours and the first MSLT nap opportunity was provided 2 hours after the end of polysornnography. Multiple Sleep Latency Tests were performed using standard methods (20) and consisted of four nap tests at 2-hour intervals unless one SOREMP occurred in which case a fifth nap test was added. Polysornnograms and MSLTs were scored in 30-second epochs using standard criteria (21) . For polysornnograms and MSLTs, sleep latency was defined as the time from lights out to the first epoch scored as sleep, and a SOREMP was defined as the occurrence of an epoch of REM sleep within 15 minutes after the first epoch scored as sleep.
Our diagnostic criteria for narcolepsy for this study are shown in Table 1 . The definition of cataplexy for this study was definite bilateral weakness of brief duration brought on by emotion. We did not consider a mere "feeling" of weakness with emotion sufficient for a diagnosis of definite cataplexy. Patients with possible cataplexy or ambiguous cataplexy were not included in the group with cataplexy. Our diagnostic criteria differed from International Classification of Sleep Disorders (ICSD) criteria (22) , principally in that we used a cut-off value for the mean sleep latency of <8 minutes, while the ICSD uses a cut-off of <5 minutes. Diagnostic criteria for patients without narcolepsy was consistent with the ICSD. Patients with narcolepsy and another sleep disorder such as sleep apnea were classified as narcoleptic.
To assess narcoleptic symptoms in patients who were not diagnosed with narcolepsy, we reviewed subject responses to several items of a 66-item sleep questionnaire, composed in part from items derived from the Stanford sleep questionnaire and assessment of wakefulness (Miles) (23) . Seventy-three percent (n = 1,512) of the subjects had completed the questionnaire. Subjects were instructed to answer the questions as Positive predictive values and (NPVs) were calculated according to the following formulas where x is the assumed prevalence in the population: One hundred seventy subjects, aged 6-79 years, were diagnosed with narcolepsy, including 106 (62%) with cataplexy and 64 without cataplexy. For the 1,913 patients without narcolepsy, we defined two groups: 1) sleep-related breathing disorders (SRBD), including obstructive sleep apnea, central sleep apnea, upper airway resistance syndrome, and hypo ventilation syndromes (SRBD; n = 1251; age range 6-85 years) and 2) all sleep disorders other than narcolepsy and SRBDs (OtherSD) (OtherSD; n = 662; age range 3-90 years).
Diagnoses for patients in the OtherSD group included subjects with idiopathic hypersomnia or possible but unproved narcolepsy (n = 71), periodic limb movement disorder and restless legs syndrome (n = 86), insufficient sleep syndrome (n = 75), parasomnias (n = 67), circadian rhythm sleep disorders (n = 34), sleep disorders due to medical, neurological, or psychiatric disorders (n = 108), insomnia from a variety of other causes (n = 60), and other diagnoses including patients with sleep related symptoms in whom no definite sleep-related diagnosis was determined (n = 161). Polysomnographic findings are summarized in Table 2 .
The MSLT findings are summarized in Table 3 . Two or more SOREMPs occurred during the initial diagnostic MSLT in 80% of the narcoleptic subjects and in 6.6% of the non-narcoleptic subjects. The frequency ~f this finding among narcoleptics and non-narcoleptlcs was similar in men and women. Figure 1 shows the proportion of narcoleptics with and without cataplexy who had two or more SOREMPs or a mean sleep latency <5 minutes or both on their initial MSLTs. In all groups except the OtherSD group, higher numbers of SOREMPs were associated with shorter sleep latencies (Fig. 2) . The frequency distribution of the mean sleep latencies for the subjects with narcolepsy and those with SRBDs is shown in Fig. 3 . Two narcoleptic subjects had mean sleep latencies >13 minutes on their initial MSLTs. One I8-year-old subject with narcolepsy and definite cataplexy, as well as a positive family history for narcolepsy-catap1exy, was initially studied during a psychotic episode that may have been the initial manifestation of schizophrenia and had a mean sleep latency of 18 minutes. During a medication-free remission from psychosis, a repeat MSLT showed a mean sleep latency of 7 minutes. The second subject, a middle-aged woman with narcolepsy without cataplexy (subject B in Table 4 ) who was first studied the day after her sister was admitted to a psychiatric hospital, had a mean sleep latency of 16.6 minutes. A subsequent polysomnogram several months later demonstrated a SOREMp, and a follow-up MSLT revealed a mean sleep latency of 4.7 minutes. A third MSLT performed at another institution revealed three sleep onset REM periods. We believe that the stimulating effects of acute psychosis in the first subject and of acute anxiety related to the sister's condition in the second subject led to the high initial mean sleep latencies.
Thirty-three narcoleptic subjects had at least one additional MSLT (Table 4) . Additional MSLTs were done for diagnostic purposes when narcolepsy was strongly suspected, for diagnostic purposes after treatment of coexisting sleep apnea, or in some cases after diag- nosis to provide baseline data for research studies. Five of 15 subjects with an initial MSLT that met both criteria had a follow-up MSLT that did not meet one or both of the criteria. On the follow-up MSLT, all five had less than two SOREMPs, while only one of the five had a mean sleep latency >5 minutes. Only one of the five had significant sleep apnea; this subject had an apnea-hypopnea index (apneas plus hypopneas per hour of sleep) of 13.1 and MSLTs with a mean sleep latency of 2.5 minutes and two SOREMPs initially and a mean sleep latency of 3.1 with no SOREMP on follow-up after treatment with nasal continuous positive airway pressure (nCPAP). We retained the diagnosis of narcolepsy in this subject because of clinical and MSLT evidence that her sleepiness did not improve after treatment of sleep apnea. Two subjects with definite cataplexy had no SOREMP during polysomnography, initial MSLTs, and subsequent MSLTs. Of the six subjects with narcolepsy without cata- plexy who did not have two or more SOREMPs on the initial MSLT, diagnosis was based on the occurrence of two or more SOREMPs with a mean sleep latency <5 minutes on a follow-up MSLT (n = 4), the occurrence of two or more SOREMPs with a mean sleep latency of 6.4 minutes on a follow-up MSLT after an initial MSLT showed one SOREMP and a mean sleep latency of 3.2 minutes (subject C in Table  4 ), and a SOREMP on polysomnography combined with a third MSLT performed at another institution that showed three SOREMPs (subject B described above).
To investigate the possibility that some subjects diagnosed with SRBDs also had concurrent narcolepsy as a cause of the finding of two or more SOREMPs on MSLT, we determined the frequency of reports of hypnagogic hallucinations, sleep paralysis, and weakness with emotion in patients diagnosed with SRBDs. Subjects with SRBDs and two or more SOREMPs did not report these symptoms more frequently than those with less than two SOREMPs, suggesting that narcolepsy was not the cause of SOREMPs in these subjects (Table 5) .
We calculated sensitivities and specificities for diagnosis of narcolepsy of several combinations of MSLT findings and of the occurrence of a sleep onset REM period on the polysomnogram (Table 6 ). We also calculated the PPV sand NPV s for narcolepsy of these combinations based on our observation that ~ 10% of patients who had MSLTs at our sleep center were diagnosed with narcolepsy. Although sensitivity was highest when the diagnostic criterion was two or more SOREMPs, the PPV for this criterion was only 57%; that is, 43% of subjects with this finding did not have narcolepsy. Although specificity (99.2%) and PPV (87%) were highest for the combination of three or more SOREMPs with a mean sleep latency of <5 minutes, only 46% of narcoleptic subjects met these criteria, and 6% of all subjects who did not have these findings were diagnosed with narcolepsy. The occurrence of a SOREMP on a polysomnogram had a higher specificity and a higher PPV for narcolepsy than the occurrence of two or more SOREMPs on an MSLT, and the occurrence of a SOREMP on polysomnography combined with a sleep latency on polysomnography of < 10 minutes had a specificity almost equal to the best specificity of any combination of MSLT criteria. We examined the clinical characteristics of the 15 subjects who were not diagnosed with narcolepsy but had three or more SOREMPs and a mean sleep latency of <5 minutes. Two of the 15 had suspected but unproved narcolepsy in addition to obstructive sleep apnea of moderate severity. Of the remaining 13, nine had plausible reasons for frequent SOREMPs, including eight with severe obstructive sleep apnea (apneahypopnea index >60 or a minimum oxyhemoglobin saturation during sleep <65% or both) and one with severe sleep disruption associated with chronic renal failure and restless legs syndrome. Of the other four, three had a history of alcohol abuse combined with obstructive sleep apnea of mild-to-moderate severity and one had sleep walking and an average of 46 periodic leg movements per hour of sleep. These results suggest that three or more SOREMPs rarely occur on the MSLT in the absence of narcolepsy or severe sleep apnea.
We also examined the clinical characteristics of the 16 subjects diagnosed with narcolepsy without cataplexy who did not meet the combined ICSD criteria on the initial MSLT of a mean sleep latency <5 minutes and two or more SOREMPs on MSLT. Of these, eight had follow-up MSLTs that met both criteria. The other eight had histories of excessive sleepiness since childhood or adolescence, no other apparent cause for sleepiness, and MSLTs with two or more SOREMPs and mean sleep latencies <8 minutes but >5 minutes. If we had used strict ICSD criteria for the diagnosis of narcolepsy and classified these 16 subjects as nonnarcoleptic, the sensitivity of the usual MSLT criteria (mean sleep latency <5 minutes and 2:2 SOREMPs) would have been 77% instead of 70%, the specificity would have been almost identical (96.9% instead of 96.7%), and the PPV would have been 73% instead of 70%.
Recent estimates suggest that symptomatic sleep apnea may be lOOX more prevalent than narcolepsy (24, 25) . Based on our findings, but assuming a 1 % prevalence of narcolepsy in a tested population, the PPV s of MSLT findings would be much lower. Only 11 % of subjects with two or more SOREMPs and 37% of subjects with a mean sleep latency of <5 minutes and three or more SOREMPs would have narcolepsy.
DISCUSSION
The MSLT is the most widely accepted objective assessment of daytime sleepiness and is commonly used to help confirm a diagnosis of narcolepsy. The mUltiple opportunities to fall asleep during the MSLT increase the likelihood that sleep onset REM periods will be observed compared to a single-nap test or to a polysornnogram. Although our data confirm the findings of many others that sleep onset REM periods are increased in patients with narcolepsy, they also indicate that over emphasis of the MSLT results may lead to misdiagnosis of other sleep disorders as narcolepsy and may prevent diagnosis of narcolepsy in some patients who actually have the disorder.
Potential for misdiagnosis of other sleep disorders as narcolepsy
Our data indicate that two or more sleep onset REM periods occur in about 7% of patients with SRBDs and a variety of other sleep disorders. With the increasing recognition of the high prevalence of sleep apnea and the serious morbidity associated with the disorder, patients with sleep apnea are likely to constitute an increasingly large proportion of the total population of patients referred for sleep laboratory testing. Thus, the potential for misdiagnosis of narcolepsy is likely to increase if clinicians perform MSLTs routinely in patients with sleepiness and suspected sleep apnea and if the finding of two or more SOREMPs is then taken as evidence of narcolepsy.
Consideration of MSLT findings in combination with clinical evidence is more valuable for diagnosis than interpretation of MSLT findings in isolation. The occurrence of two SOREMPs on MSLT in a patient with sleepiness that began in adulthood in association with weight gain and increased volume of snoring is less likely to be due to narcolepsy than the same finding in a nonsnoring patient with a stable body weight and sleepiness since childhood. In patients with SRBDs and MSLT findings suggestive of narcolepsy, we recommend treatment of the breathing disorder followed by clinical reassessment and further testing only if the patient remains excessively sleepy.
Potential for misdiagnosis of narcolepsy as another sleep disorder
As some patients with narcolepsy do not have frequent sleep onset REM periods during an MSLT, the potential exists that some patients with narcolepsy will not be diagnosed correctly if the ICSD-specified diagnostic criteria are adhered to strictly. We found two or more SOREMPs in 74% of narcoleptics with cataplexy and in 91 % of those without cataplexy, findings which are not strikingly different from those of Guilleminault et al. (26) who found two or more SOREMPs in 83.5% of narcoleptics with cataplexy. Eight subjects, whom we diagnosed with narcolepsy but did not meet ICSD criteria because of mean sleep latencies between 5 and 8 minutes, had clinical features identical to patients with shorter mean sleep latencies.
Our data also indicate that the occurrence of sleep onset REM periods in some narcoleptics may vary from one MSLT to another. To our knowledge, only three studies have assessed test-retest reliability of the MSLT. In a study of six insomniacs, the correlation of mean sleep latencies on the test and retest was 0.65, indicating that the initial result explained only 42% of the variance in the second result (27) . In a study of 14 normal controls, the mean sleep latency was highly reliable, but data about SOREMPs were not reported (28) . In the only study of narcoleptics, by Folkerts et al. (29) , two or more SOREMPs, which were required for diagnosis, were present in 28 of 30 subjects upon repeat testing. However, these authors included sleep onset REM periods from the prior night of polysomnography in the total of SOREMPs. Their data indicate that two or more SOREMPs occurred on both MSLTs for at least 23 and at most 28/30 subjects (77-93%). Regarding the reliability of the mean sleep latency, Folkerts et al. (29) used a cut-off for the mean sleep latency of 10 minutes. Using the cut-off of 5 minutes specified by the ICSD, 27 of their 30 subjects (90%) had a mean sleep latency of <5 minutes on the first test and 26 (87%) had a mean sleep latency <5 minutes on both tests. This result is similar to our finding Sleep, Vol. 20, No. 8, 1997 of a mean sleep latency less than 5 minutes in 87% of narcoleptics with cataplexy and 81 % of those without cataplexy. Because only a small selected subset of our subjects had repeat testing, our results indicating substantial variability from one MSLT to the next are not generalizable to narcoleptics as a whole. Many of our subjects who had repeat studies were retested precisely because narcolepsy was a suspected diagnosis and the initial study was not diagnostic.
Our findings suggest that follow-up MSLTs are valuable for patients with suspected narcolepsy when the clinical suspicion of the disorder is high and the initial study is not diagnostic. Limitation of testing to a single MSLT, as a consequence of refusal of insurers to reimburse for additional testing or for other reasons, may lead to misdiagnosis in some cases.
Diagnostic value of SOREMPs and short mean sleep latency on MSL T
On the other hand, our findings also confirm that MSLT findings do have significant diagnostic value. The value of SOREMPs is a function of the number of episodes; the occurrence of two SOREMPs on an MSLT is less specific for narcolepsy than the occurrence of three or more SOREMPs. The value is also a function of the timing of the episodes. The PPV for narcolepsy of a sleep onset REM period at the onset of a nighttime polysomnogram (68%) exceeds that of the occurrence of two sleep onset REM periods on an MSLT (57%).
A short mean sleep latency is also a useful finding. In subjects who had more than one MSLT, we found greater consistency of the mean sleep latency than of the number of SOREMPs. The similarity of clinical features in the eight patients with two or more SOREMPs and mean sleep latencies of 5-8 minutes to patients with mean sleep latencies <5 minutes suggests that an 8-minute cutoff may be more appropriate than 5 minutes. On the other hand, seven narcoleptics with cataplexy had mean sleep latencies of 8 minutes or greater, and we believed, on clinical grounds, that narcolepsy was probable but unproved in five subjects who we classified as non-narcoleptic and who had two or more SOREMPs and mean sleep latencies of 8 minutes or greater (range 8.3-10 minutes).
The only narcoleptic subjects with mean sleep latencies > 13 minutes had psychiatric reasons that likely accounted for their difficulty falling asleep. Our findings therefore indicate that narcolepsy is extremely unlikely if the mean sleep latency on the MSLT is > 13 minutes and there is no acute psychiatric condition present at the time of testing. In patients with complaints of fatigue in whom it is difficult to determine on clinical grounds whether the complaint includes a component of excessive sleepiness, a mean sleep latency > 13 minutes on the MSLT effectively excludes narcolepsy as a diagnosis and a mean sleep latency >8 minutes indicates that narcolepsy is highly unlikely.
Potential weaknesses of the study A weakness of our study is the use of findings on polysornnography and the MSLT as initial diagnostic criteria. In any study that assesses diagnostic criteria for a syndrome that lacks a definitive pathophysiologic marker, the results will be affected by the initial criteria used for diagnosis. We attempted to limit the impact of this weakness by separating patients with definite cataplexy from those without definite cataplexy. In our center, patients with cataplexy are diagnosed with narcolepsy based on clinical criteria, and the MSLT is used to provide supporting evidence. That the sensitivity of MSLT criteria was similar in narcoleptics with and without cataplexy (67% and 75%) suggests that this weakness does not invalidate our results.
Although another potential weakness is our use of a mean sleep latency of 8 minutes as a cut-off rather than the ICSD-specified 5 minutes, our recalculations of the sensitivity, specificity, and PPVs, assuming that we had used ICSD criteria, yielded similar results.
A third potential weakness of the study is the use of clinical findings, particularly cataplexy, to define the syndrome. Cataplexy can be difficult to diagnose and Hublin et al. (24) found that 6% of the general population experienced a "feeling" of weakness with emotion. We do not have data on intra-and inter-rater reliability of the finding of cataplexy in this set of patients. However, our use of criteria for definite cataplexy was intended to limit misdiagnosis of cataplexy. Our criteria for "definite cataplexy" are almost identical to those of Honda (30) with the exception that we do not require a positive response to tricyclic antidepressants. In 190 Japanese subjects diagnosed by Honda's criteria, 100% were positive for the human leukocyte antigen (HLA) DR2 (31) , suggesting that use of these criteria, at least by the Japanese investigators, leads to a low incidence of falsely positive diagnoses, as one would expect a substantial proportion of misdiagnosed individuals to be negative for HLA DR2. We recently performed HLA testing on 23 subjects with sleepiness and definite cataplexy by our criteria and found that all were positive for HLA DRI5 and HLA DQI (Aldrich, unpublished data), suggesting that we also have a low incidence of falsely positive diagnoses of cataplexy.
Implications for the diagnosis of narcolepsy
Our findings raise a number of questions concerning the most effective way to diagnose narcolepsy. Some authors have suggested that laboratory studies are not needed for diagnosis. Honda (30) proposed two diagnostic criteria: I) recurrent brief daytime sleep episodes occurring almost every day for at least 6 months that are refreshing, that are easily terminated with stimulation, and that respond to stimulant medications and 2) cataplexy, defined as sudden brief bilateral loss of skeletal muscle tone that is provoked by strong emotion and that improves with imipramine or clomipramine. Other symptoms associated with narcolepsy are less useful than cataplexy for diagnosis. Aldrich (32) reported a substantial incidence of hypnagogic hallucinations, sleep paralysis, and automatic behavior in patients with idiopathic hypersomnia, mild sleepdisordered breathing, or excessive sleepiness of uncertain cause.
It seems reasonable, therefore, to emphasize cataplexy as a major feature for the diagnosis of narcolepsy, and the use of cataplexy as a requirement for diagnosis of narcolepsy yields a more homogeneous group than the use of multiple SOREMPs (18) . On the other hand, subjects without cataplexy who have been diagnosed with narcolepsy based on ICSD criteria appear to have an increased likelihood of having the HLA DR2 compared to persons without narcolepsy (reviewed in ref. 33) , suggesting that some patients without cataplexy have the genotype associated with narcolepsy-cataplexy. Patients diagnosed with narcolepsy without cataplexy often have clinical features, laboratory findings, and responses to therapy that are identical to those seen in narcoleptic patients with cataplexy. Such patients would not be diagnosed with narcolepsy if the presence of definite cataplexy is required for diagnosis. Furthermore, some narcoleptics develop cataplexy years after the onset of excessive sleepiness (34) , and in some, cataplexy disappears in the course of the disease. Finally, the presence of cataplexy is usually determined from the patient's history rather than by direct observation of a cataplectic episode, and the possibility of malingering or a conversion disorder must be considered (35) .
Our findings suggest that it may not be possible in all patients to conclude definitively that narcolepsy is or is not present. It may be preferable to use a diagnostic scheme similar to that used for multiple sclerosis, with categories of definite, probable, and possible narcolepsy. Patients with definite narcolepsy, based on an unambiguous history of cataplexy, may not require an MSLT, while patients with possible or probable narcolepsy may require more than one MSLT as well as additional diagnostic studies such as HLA testing for more definitive diagnosis.
Our findings argue against the practice of performing a MSLT in all patients who complain of excessive sleepiness if the purpose is only to determine whether the patient has narcolepsy. The MSLT provides objective assessment of sleepiness in patients with a variety of sleep disorders, but its PPV for narcolepsy is likely to be highest when its use is confined to patients in whom there is a reasonable likelihood of the disorder based on clinical criteria. Clinical features in addition to cataplexy that increase the likelihood of narcolepsy in comparison to sleep apnea include onset of symptoms in teenage years, absence of snoring and witnessed apnea, normal or near normal body weight, and absence of hypertension.
Given the problems with exclusive reliance on the MSLT for diagnosis of narcolepsy and the pressures to contain costs in the evaluation of patients with sleep disorders, some may conclude that the MSLT has little value and is not required at all. We believe that such an approach is ill-advised and is likely to increase misdiagnosis or nondiagnosis of persons with narcolepsy. Although the occurrence of a SOREMP on polysomnography has a high PPV for narcolepsy, this finding cannot be used in place of the MSLT because the sensitivity is low and large numbers of narcoleptics will not be diagnosed based on such an approach. Clinicians who do not use the MSLT at all may tend to focus their diagnostic efforts mainly on sleep apnea, and patients with complaints of excessive sleepiness who are found to have little or no sleep-disordered breathing may not undergo thorough diagnostic evaluation.
The MSLT provides an objective measure of daytime sleepiness; the inability of patients to voluntarily reduce sleep latencies, except by depriving themselves of sleep or by taking sedative medications, reduces the likelihood that patients who are not excessively sleepy will be able to manipulate the test results. The occurrence of short sleep latencies and frequent SOREMPs increases the likelihood of narcolepsy, but MSLT results alone are not sufficient in many clinical settings to diagnose or exclude narcolepsy definitively. Our results suggest that the indications for the MSLT and the interpretation of its results are strongly dependent on the clinical setting.
